| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
IMV Inc (TO: IMV)
IMV Technical Analysis
4
| As on 8th Jun 2023 IMV STOCK Price closed @ 1.12 and we RECOMMEND Sell for LONG-TERM with Stoploss of 1.14 & Strong Sell for SHORT-TERM with Stoploss of 1.58 we also expect STOCK to react on Following IMPORTANT LEVELS. |
IMVSTOCK Price
| Open | 1.12 | Change | Price | % |
| High | 1.12 | 1 Day | 0.00 | 0.00 |
| Low | 1.12 | 1 Week | 0.00 | 0.00 |
| Close | 1.12 | 1 Month | 0.12 | 12.00 |
| Volume | N/A | 1 Year | -0.56 | -33.33 |
| 52 Week High 4.97 | 52 Week Low 0.30 | ||||
TO Canada Most Active Stocks
| YRI | 7.89 | 0.13% |
| CNQ | 49.67 | % |
| MFC | 36.84 | % |
| SU | 54.90 | % |
| UEX | 0.50 | 16.28% |
| BMO | 112.04 | % |
| SJR-B | 40.48 | 0.02% |
| ENB | 53.36 | % |
| VFF | 8.12 | 0.87% |
| BNS | 67.22 | % |
TO Canada Top Gainers Stocks
TO Canada Top Losers Stocks
| IMV Daily Charts |
IMV Intraday Charts |
Whats New @ Bazaartrend |
IMV Free Analysis |
|
|
IMV Important Levels Intraday
| RESISTANCE | 1.12 |
| RESISTANCE | 1.12 |
| RESISTANCE | 1.12 |
| RESISTANCE | 1.12 |
| RESISTANCE | 1.12 |
| RESISTANCE | 1.12 |
| RESISTANCE | 1.12 |
| RESISTANCE | 1.12 |
IMV Forecast September 2024
| 4th UP Forecast | 1.93 |
| 3rd UP Forecast | 1.67 |
| 2nd UP Forecast | 1.51 |
| 1st UP Forecast | 1.35 |
| 1st DOWN Forecast | 0.89 |
| 2nd DOWN Forecast | 0.73 |
| 3rd DOWN Forecast | 0.57 |
| 4th DOWN Forecast | 0.31 |
IMV Weekly Forecast
| 4th UP Forecast | 1.83 |
| 3rd UP Forecast | 1.60 |
| 2nd UP Forecast | 1.46 |
| 1st UP Forecast | 1.32 |
| 1st DOWN Forecast | 0.92 |
| 2nd DOWN Forecast | 0.78 |
| 3rd DOWN Forecast | 0.64 |
| 4th DOWN Forecast | 0.41 |
IMV Forecast2024
| 4th UP Forecast | 12.1 |
| 3rd UP Forecast | 8.58 |
| 2nd UP Forecast | 6.4 |
| 1st UP Forecast | 4.23 |
| 1st DOWN Forecast | -1.99 |
| 2nd DOWN Forecast | -4.16 |
| 3rd DOWN Forecast | -6.34 |
| 4th DOWN Forecast | -9.86 |
IMV Inc ( TO Canada Symbol : IMV )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
IMV Business Profile
IMV Inc., a biopharmaceutical company, focuses on the development of cancer immunotherapies and vaccines against infectious diseases using its DPX delivery technology platform. The company's lead drug candidate includes maveropepimut-S (DPX-Survivac), a T cell therapy, which is in three Phase II clinical trials across 6 different cancer indications with and without Merck's Keytruda; and Phase II clinical trials for the treatment of ovarian cancer, and recurrent and refractory diffuse large B cell lymphoma. It is also developing DPX-COVID-19, a second-generation vaccine against severe acute respiratory syndrome coronavirus 2; and DPX-RSV, a vaccine candidate, which has completed Phase I clinical trials for the treatment of respiratory syncytial virus strain A, as well as DPX-SurMAGE for the treatment of bladder cancer and DPX-BRAF to treat melanoma patients. The company was formerly known as Immunovaccine Inc. and changed its name to IMV Inc. in May 2018. IMV Inc. was founded in 2000 and is headquartered in Dartmouth, Canada. Address: 130 Eileen Stubbs Avenue, Dartmouth, NS, Canada, B3B 2C4
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service